Delivery Order SPE2DR25D2007-SPE2DR26FM31B
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 5, 2025, for the supply of Ayvakit 25 mg tablets in a quantity of 30 units, with a ceiling value of $25,681.09 and firm fixed pricing. This competitive, non-set-aside delivery order is scheduled for completion by November 28, 2025, and will be performed at the contractor's Conshohocken, Pennsylvania location. The contract represents a child award issued under AmerisourceBergen's larger indefinite...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on June 18, 2025, for the supply of AYVAKIT 25 MG tablets (30-count units) with a ceiling value of $73,106.76. This is a firm fixed-price delivery order with an ultimate completion date of July 11, 2025, and was competitively awarded with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical...
- The Defense Logistics Agency awarded a delivery order valued at $25,681.09 to AmerisourceBergen Drug Corp for AYVAKIT 25 mg tablets (30-count supply) on December 5, 2025, with an ultimate completion date of December 29, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at AmerisourceBergen's Conshohocken, Pennsylvania facility. The delivery order is a child contract issued under AmerisourceBergen's broader Indefinite Delivery...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of AYVAKIT 25 mg tablets (30-count packaging) under a firm fixed price contract valued at approximately $24.4K. This is a non-set-aside, competitively awarded delivery order with an ultimate completion date of August 21, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child...
- The Defense Logistics Agency awarded a $25,717.85 firm fixed price delivery order to AmerisourceBergen Drug Corp on December 23, 2025, for the supply of AYVAKIT 200 mg tablets (30-count units) with a completion date of January 15, 2026. The award was competitively procured with no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC)...
- This delivery order, awarded to AmerisourceBergen Drug Corp on August 18, 2025, provides for the supply of AYVAKIT 25 mg tablets (30-count units) valued at $24,368.92 with a completion date of September 9, 2025. The contract is a firm fixed-price delivery order with no set-aside designation, awarded competitively through the Defense Logistics Agency (DLA), which procures medical supplies for the Department of Defense. Performance will be conducted from the contractor's corporate office in...
- This delivery order, awarded on August 25, 2025, authorizes AmerisourceBergen Drug Corp to supply 30 tablets of Ayvakit 25 mg under a firm fixed-price arrangement with a ceiling value of $24,368.92. The contract is performed at the company's corporate office in Conshohocken, Pennsylvania, and must be completed by September 16, 2025. The Defense Logistics Agency, under the Department of Defense, issued this non-competitive delivery order as a child contract utilizing AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $24,368.92 to AmerisourceBergen Drug Corp for the supply of AYVAKIT 25 mg tablets (30-count packages) under a firm fixed-price contract. The award, issued on September 8, 2025, with an ultimate completion date of September 29, 2025, represents a non-competitive delivery order executed by the pharmaceutical distributor's corporate office located in Conshohocken, Pennsylvania. This order falls under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $25,717.85 to AmerisourceBergen Drug Corp for the supply of AYVAKIT (avapritinib) 200 mg tablets in a 30-count configuration. This firm fixed-price delivery order, issued on November 25, 2025, with an ultimate completion date of December 17, 2025, represents a non-competitive award under the company's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX). AmerisourceBergen, headquartered in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $51,362.20 to AmerisourceBergen Drug Corp for AYVAKIT (avapritinib) 25 mg tablets in a quantity of 30 units. The contract, issued on December 17, 2025, represents a firm fixed-price delivery order with an ultimate completion date of January 9, 2026. This award was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- SPE2DR25D2007Indefinite Delivery Contract
- SPE2DR25D2007-SPE2DR26FM31BDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 29, 2025, for the supply of Ayvakit 25 mg tablets (30-count) with a ceiling value of $25,681.09. This competitively awarded, firm fixed-price delivery order is scheduled for completion by January 21, 2026, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award carries no set-aside designation, indicating it was competed among qualified vendors in the open market. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 through December 2026. AmerisourceBergen Drug Corp serves as a prime contractor for the Defense Logistics Agency's Medical Supply Chain, providing a broad portfolio of pharmaceutical products and medical supplies to support military and federal healthcare systems. The company's extensive federal contracting history demonstrates its capability to deliver specialized medications across multiple therapeutic domains to support Department of Defense and veteran healthcare requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $25.7k | 12/28/25 |